v3.26.1
Business Segment Information - Schedule of Operating Results for the Business Segments (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Apr. 30, 2026
Apr. 30, 2025
Apr. 30, 2026
Apr. 30, 2025
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue $ 179 $ 362 $ 630 $ 567
COSTS AND EXPENSES        
General and administrative (2,140) (3,170) (7,260) (8,284)
Research and development (4,853) (3,003) (16,866) (5,276)
Depreciation and amortization (48) (62) (153) (238)
Loss on impairment of goodwill (3,050)
(Loss) income from operations (6,870) (5,913) (23,678) (16,396)
Healthcare [Member]        
COSTS AND EXPENSES        
General and administrative (2,079) (3,102) (7,074) (7,794)
Research and development (4,852) (3,003) (16,855) (5,021)
Depreciation and amortization (29) (13) (98) (15)
Loss on impairment of goodwill      
(Loss) income from operations (6,879) (5,884) (23,688) (12,596)
Infusion Technology [Member]        
COSTS AND EXPENSES        
General and administrative (7) (37) (36) (292)
Research and development (1) (11) (255)
Depreciation and amortization (34) (177)
Loss on impairment of goodwill       (3,050)
(Loss) income from operations (8) (60) (47) (3,787)
Real Estate [Member]        
COSTS AND EXPENSES        
General and administrative (54) (31) (150) (198)
Research and development
Depreciation and amortization (19) (15) (55) (46)
Loss on impairment of goodwill      
(Loss) income from operations 17 31 57 (13)
Product Revenue [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue 89 243 368 243
COSTS AND EXPENSES        
Cost of product revenue (8) (9) (29) (9)
Product Revenue [Member] | Healthcare [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue 89 243 368 243
Product Revenue [Member] | Infusion Technology [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue
Product Revenue [Member] | Real Estate [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue
Rental – Third Party [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue 60 49 173 147
Rental – Third Party [Member] | Healthcare [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue
Rental – Third Party [Member] | Infusion Technology [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue
Rental – Third Party [Member] | Real Estate [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue 60 49 173 147
Rental – Related Party [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue 30 28 89 84
Rental – Related Party [Member] | Healthcare [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue
Rental – Related Party [Member] | Infusion Technology [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue
Rental – Related Party [Member] | Real Estate [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue 30 28 89 84
Cost of Product Revenue [Member]        
COSTS AND EXPENSES        
Cost of product revenue (8) (9) (29) (9)
Cost of Product Revenue [Member] | Healthcare [Member]        
COSTS AND EXPENSES        
Cost of product revenue (8) (9) (29) (9)
Cost of Product Revenue [Member] | Infusion Technology [Member]        
COSTS AND EXPENSES        
Cost of product revenue
Cost of Product Revenue [Member] | Real Estate [Member]        
COSTS AND EXPENSES        
Cost of product revenue
Infusion Technology Revenue [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue   42   93
Infusion Technology Revenue [Member] | Healthcare [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue    
Infusion Technology Revenue [Member] | Infusion Technology [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue   42   93
Infusion Technology Revenue [Member] | Real Estate [Member]        
Schedule of Operating Results for the Business Segments [Line Items]        
Revenue    
Cost of Infusion Technology Revenue [Member]        
COSTS AND EXPENSES        
Cost of product revenue   (31)   (106)
Cost of Infusion Technology Revenue [Member] | Healthcare [Member]        
COSTS AND EXPENSES        
Cost of product revenue    
Cost of Infusion Technology Revenue [Member] | Infusion Technology [Member]        
COSTS AND EXPENSES        
Cost of product revenue   (31)   (106)
Cost of Infusion Technology Revenue [Member] | Real Estate [Member]        
COSTS AND EXPENSES        
Cost of product revenue